Clinical Trials Browser

Completed × Non-Squamous Non-Small Cell Lung Cancer × onartuzumab × Clear all

NCT01456325 2016-11-02

A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

Phase 3 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01887886 2016-11-02

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 3 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01496742 2016-09-23

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01519804 2016-09-02

A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

Non-Squamous Non-Small Cell Lung Cancer